Compounds
Peptide Levels Over Time
Understanding Peptide Half-Life and Pharmacokinetics
The Peptide Half-Life Tracker is an advanced pharmacokinetic tool designed to visualize how peptides degrade in the body over time. By inputting the dose, half-life, and dosing frequency, researchers can model plasma concentration curves. This helps in understanding peak serum levels, trough levels, and the time required to reach a steady state.
What is Biological Half-Life?
Biological half-life refers to the time it takes for the concentration of a substance (like a peptide) in the body to reduce by half. For example, if a peptide has a half-life of 24 hours, 50% of the initial dose will remain active after one day. Understanding this decay rate is crucial for determining optimal dosing schedules and avoiding unwanted accumulation or rapid depletion.
Why Track Multiple Peptides?
Many research protocols involve the simultaneous use of multiple peptides (e.g., combining CJC-1295 with Ipamorelin). Our tracker allows you to overlay multiple decay curves on a single interactive chart. This provides a comprehensive view of how different compounds interact pharmacokinetically, ensuring that peak levels align according to your research goals.
Peptide Half-Life Quick Reference
How long does semaglutide stay in your system?
Semaglutide has a half-life of approximately 7 days (168 hours). It is largely eliminated after 5 weeks. Weekly dosing produces near-steady-state plasma levels after 4–5 weeks.
How long does BPC-157 stay active in the body?
BPC-157 has a short half-life of approximately 4–6 hours. It is largely cleared within 24 hours. Twice-daily dosing is commonly used for more sustained plasma levels.
What is the half-life of Ipamorelin, CJC-1295, and other GH secretagogues?
Ipamorelin: ~2 hours (typically dosed 1–3×/day). CJC-1295 without DAC: ~30 minutes (dosed with Ipamorelin for synergistic GH pulse). CJC-1295 with DAC: ~7–8 days (once-weekly dosing). Sermorelin: 10–20 minutes.
What does steady-state mean for peptide dosing?
Steady state is reached when the amount of compound entering the body equals the amount being eliminated, resulting in stable plasma levels. It takes approximately 4–5 half-lives. For semaglutide, steady state is reached after ~5 weeks of weekly dosing. For BPC-157, it is reached within 24–48 hours of twice-daily dosing.
Built by Will Wright — Available for hire